Histological processes in HCM Four histological processes in hypertrophic cardiomyopathy (HCM): Myocyte hypertrophy Myocyte and myofibrillar disarray Small vessel disease Fibrosis Reference McKenna WJ, Moon JC, Sulaiman A.
Assessing SCD risk in HCM by CMR Sudden cardiac death (SCD) is one of the dreaded complications of hypertrophic cardiomyopathy (HCM) and predicting it is always challenging. Clinical
Atrial functional mitral regurgitation Atrial functional mitral regurgitation (MR) has been featured as the JACC Review Topic of the Week [1]. Atrial functional MR is due to isolated
Diagnostic criteria for peripartum cardiomyopathy Diagnostic criteria for peripartum cardiomyopathy are: Development of heart failure in the last month of pregnancy or within 5 months after delivery Left
Cardiovascular risk in cancer survivors Improvements in cancer care has its impact on better survival of those with early stage disease in several malignancies. In this scenario, cardiovascular
SGLT2 inhibitors and GLP-1 receptor agonists for diabetics with heart failure Sodium glucose cotransporter 2 inhibitors (SGLT2-i) and glucagon-like peptide-1 receptor agonists (GLP-1 RA) are two new promising
Extreme high high-density lipoprotein (HDL) cholesterol may paradoxically increase risk Usually, high-density lipoprotein (HDL) cholesterol concentrations are inversely associated with cardiovascular disease and mortality. But there is some
Antibiotic effect of ticagrelor Ticagrelor is a reversible platelet adenosine diphosphate P2Y12 receptor (P2Y12) inhibitor and is quite effective as an antiplatelet agent. New research suggests an antibiotic
Ticagrelor vs other P2Y12 inhibitors Ticagrelor is a reversible P2Y12 receptor inhibitor whereas clopidogrel and prasugrel are irreversible inhibitors. Ticagrelor does not require metabolic activation, absorption is rapid
Triboelectric pacemaker powered by cardiac contractions Usually modern pacemakers are powered by built-in batteries and you need to replace the pulse generator when the battery reaches end of
